Viewing Study NCT05744466


Ignite Creation Date: 2025-12-24 @ 4:18 PM
Ignite Modification Date: 2026-01-25 @ 12:20 AM
Study NCT ID: NCT05744466
Status: RECRUITING
Last Update Posted: 2024-07-23
First Post: 2023-01-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
Sponsor: Bristol-Myers Squibb
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: IM011-1105
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators